Jay Olson
Stock Analyst at Oppenheimer
(4.12)
# 500
Out of 5,138 analysts
244
Total ratings
44.95%
Success rate
16.07%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Maintains: Outperform | $250 → $750 | $324.08 | +131.42% | 3 | Dec 15, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Outperform | $28 → $58 | $36.58 | +58.56% | 4 | Dec 9, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Outperform | $600 → $650 | $504.95 | +28.73% | 12 | Nov 20, 2025 | |
| IBIO iBio, Inc. | Initiates: Outperform | $5 | $2.24 | +123.21% | 1 | Oct 21, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $84 → $90 | $77.53 | +16.08% | 4 | Oct 8, 2025 | |
| IMRX Immuneering | Maintains: Outperform | $21 → $30 | $4.78 | +527.62% | 3 | Sep 25, 2025 | |
| BCYC Bicycle Therapeutics | Maintains: Outperform | $48 → $44 | $6.67 | +559.67% | 4 | Aug 11, 2025 | |
| ATAI AtaiBeckley | Initiates: Outperform | $14 | $3.85 | +263.64% | 1 | Jul 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Perform | $19 → $22 | $26.29 | -16.32% | 15 | Jun 26, 2025 | |
| PRTA Prothena Corporation | Downgrades: Perform | n/a | $9.25 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $4.63 | +1,303.89% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $65 | $1.54 | +4,120.78% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $1.51 | +760.93% | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $116.22 | -35.47% | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $90 | $36.23 | +148.41% | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $42 | $17.53 | +139.59% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $41 → $33 | $43.78 | -24.62% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $40 | $12.83 | +211.77% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $20 | $3.93 | +408.91% | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $6.28 | +377.71% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $270 → $255 | $165.38 | +54.19% | 25 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $82 | $102.62 | -20.09% | 14 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $10 | $27.93 | -64.19% | 4 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $138 | $33.52 | +311.69% | 8 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $8 | $1.99 | +302.01% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $380 | $331.00 | +14.80% | 23 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $216 → $219 | $134.54 | +62.78% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $12 | $2.02 | +494.06% | 6 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 | $3.67 | +390.46% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 | $14.92 | +570.24% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $95 | $52.61 | +80.57% | 6 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $0.97 | +2,469.64% | 1 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 | $1.40 | +542.86% | 4 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,200 → $500 | $1.22 | +40,883.61% | 4 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $25 → $21 | $12.49 | +68.13% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $3.94 | - | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $84 | $17.00 | +394.12% | 1 | Mar 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $2.50 | - | 3 | Jul 11, 2017 |
Praxis Precision Medicines
Dec 15, 2025
Maintains: Outperform
Price Target: $250 → $750
Current: $324.08
Upside: +131.42%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Outperform
Price Target: $28 → $58
Current: $36.58
Upside: +58.56%
Madrigal Pharmaceuticals
Nov 20, 2025
Maintains: Outperform
Price Target: $600 → $650
Current: $504.95
Upside: +28.73%
iBio, Inc.
Oct 21, 2025
Initiates: Outperform
Price Target: $5
Current: $2.24
Upside: +123.21%
Ionis Pharmaceuticals
Oct 8, 2025
Maintains: Outperform
Price Target: $84 → $90
Current: $77.53
Upside: +16.08%
Immuneering
Sep 25, 2025
Maintains: Outperform
Price Target: $21 → $30
Current: $4.78
Upside: +527.62%
Bicycle Therapeutics
Aug 11, 2025
Maintains: Outperform
Price Target: $48 → $44
Current: $6.67
Upside: +559.67%
AtaiBeckley
Jul 29, 2025
Initiates: Outperform
Price Target: $14
Current: $3.85
Upside: +263.64%
ACADIA Pharmaceuticals
Jun 26, 2025
Maintains: Perform
Price Target: $19 → $22
Current: $26.29
Upside: -16.32%
Prothena Corporation
May 27, 2025
Downgrades: Perform
Price Target: n/a
Current: $9.25
Upside: -
May 21, 2025
Initiates: Outperform
Price Target: $65
Current: $4.63
Upside: +1,303.89%
May 15, 2025
Maintains: Outperform
Price Target: $80 → $65
Current: $1.54
Upside: +4,120.78%
May 14, 2025
Maintains: Outperform
Price Target: $15 → $13
Current: $1.51
Upside: +760.93%
May 8, 2025
Maintains: Outperform
Price Target: $70 → $75
Current: $116.22
Upside: -35.47%
Mar 14, 2025
Upgrades: Outperform
Price Target: $90
Current: $36.23
Upside: +148.41%
Mar 3, 2025
Maintains: Outperform
Price Target: $50 → $42
Current: $17.53
Upside: +139.59%
Jan 24, 2025
Downgrades: Perform
Price Target: $41 → $33
Current: $43.78
Upside: -24.62%
Jan 13, 2025
Maintains: Outperform
Price Target: $60 → $40
Current: $12.83
Upside: +211.77%
Dec 11, 2024
Maintains: Outperform
Price Target: $80 → $20
Current: $3.93
Upside: +408.91%
Dec 6, 2024
Initiates: Outperform
Price Target: $30
Current: $6.28
Upside: +377.71%
Oct 31, 2024
Maintains: Outperform
Price Target: $270 → $255
Current: $165.38
Upside: +54.19%
Oct 30, 2024
Maintains: Outperform
Price Target: $81 → $82
Current: $102.62
Upside: -20.09%
Oct 17, 2024
Maintains: Outperform
Price Target: $9 → $10
Current: $27.93
Upside: -64.19%
Sep 25, 2024
Reiterates: Outperform
Price Target: $138
Current: $33.52
Upside: +311.69%
Aug 14, 2024
Assumes: Outperform
Price Target: $8
Current: $1.99
Upside: +302.01%
Aug 7, 2024
Maintains: Outperform
Price Target: $380
Current: $331.00
Upside: +14.80%
Aug 2, 2024
Maintains: Outperform
Price Target: $216 → $219
Current: $134.54
Upside: +62.78%
Jun 18, 2024
Maintains: Perform
Price Target: $12
Current: $2.02
Upside: +494.06%
May 15, 2024
Maintains: Outperform
Price Target: $18
Current: $3.67
Upside: +390.46%
May 15, 2024
Maintains: Outperform
Price Target: $100
Current: $14.92
Upside: +570.24%
May 10, 2024
Maintains: Outperform
Price Target: $102 → $95
Current: $52.61
Upside: +80.57%
Apr 12, 2024
Initiates: Outperform
Price Target: $25
Current: $0.97
Upside: +2,469.64%
Mar 27, 2024
Maintains: Outperform
Price Target: $9
Current: $1.40
Upside: +542.86%
Nov 30, 2023
Maintains: Outperform
Price Target: $1,200 → $500
Current: $1.22
Upside: +40,883.61%
Nov 22, 2023
Maintains: Perform
Price Target: $25 → $21
Current: $12.49
Upside: +68.13%
Oct 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $3.94
Upside: -
Mar 20, 2018
Maintains: Outperform
Price Target: $70 → $84
Current: $17.00
Upside: +394.12%
Jul 11, 2017
Upgrades: Outperform
Price Target: n/a
Current: $2.50
Upside: -